1 Introduction to Research & Analysis Reports
1.1 Semi-solid Dosage Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Semi-solid Dosage Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Semi-solid Dosage Overall Market Size
2.1 Global Semi-solid Dosage Market Size: 2022 VS 2029
2.2 Global Semi-solid Dosage Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Semi-solid Dosage Sales: 2018-2029
3 Company Landscape
3.1 Top Semi-solid Dosage Players in Global Market
3.2 Top Global Semi-solid Dosage Companies Ranked by Revenue
3.3 Global Semi-solid Dosage Revenue by Companies
3.4 Global Semi-solid Dosage Sales by Companies
3.5 Global Semi-solid Dosage Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Semi-solid Dosage Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Semi-solid Dosage Product Type
3.8 Tier 1, Tier 2 and Tier 3 Semi-solid Dosage Players in Global Market
3.8.1 List of Global Tier 1 Semi-solid Dosage Companies
3.8.2 List of Global Tier 2 and Tier 3 Semi-solid Dosage Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Semi-solid Dosage Market Size Markets, 2022 & 2029
4.1.2 Ointment
4.1.3 Paste
4.1.4 Plaster
4.1.5 Gel
4.2 By Type – Global Semi-solid Dosage Revenue & Forecasts
4.2.1 By Type – Global Semi-solid Dosage Revenue, 2018-2023
4.2.2 By Type – Global Semi-solid Dosage Revenue, 2024-2029
4.2.3 By Type – Global Semi-solid Dosage Revenue Market Share, 2018-2029
4.3 By Type – Global Semi-solid Dosage Sales & Forecasts
4.3.1 By Type – Global Semi-solid Dosage Sales, 2018-2023
4.3.2 By Type – Global Semi-solid Dosage Sales, 2024-2029
4.3.3 By Type – Global Semi-solid Dosage Sales Market Share, 2018-2029
4.4 By Type – Global Semi-solid Dosage Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Semi-solid Dosage Market Size, 2022 & 2029
5.1.2 Skin
5.1.3 Nasal Cavity
5.1.4 Vaginal Cavity
5.1.5 Rectal Cavity
5.1.6 Other
5.2 By Application – Global Semi-solid Dosage Revenue & Forecasts
5.2.1 By Application – Global Semi-solid Dosage Revenue, 2018-2023
5.2.2 By Application – Global Semi-solid Dosage Revenue, 2024-2029
5.2.3 By Application – Global Semi-solid Dosage Revenue Market Share, 2018-2029
5.3 By Application – Global Semi-solid Dosage Sales & Forecasts
5.3.1 By Application – Global Semi-solid Dosage Sales, 2018-2023
5.3.2 By Application – Global Semi-solid Dosage Sales, 2024-2029
5.3.3 By Application – Global Semi-solid Dosage Sales Market Share, 2018-2029
5.4 By Application – Global Semi-solid Dosage Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Semi-solid Dosage Market Size, 2022 & 2029
6.2 By Region – Global Semi-solid Dosage Revenue & Forecasts
6.2.1 By Region – Global Semi-solid Dosage Revenue, 2018-2023
6.2.2 By Region – Global Semi-solid Dosage Revenue, 2024-2029
6.2.3 By Region – Global Semi-solid Dosage Revenue Market Share, 2018-2029
6.3 By Region – Global Semi-solid Dosage Sales & Forecasts
6.3.1 By Region – Global Semi-solid Dosage Sales, 2018-2023
6.3.2 By Region – Global Semi-solid Dosage Sales, 2024-2029
6.3.3 By Region – Global Semi-solid Dosage Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Semi-solid Dosage Revenue, 2018-2029
6.4.2 By Country – North America Semi-solid Dosage Sales, 2018-2029
6.4.3 US Semi-solid Dosage Market Size, 2018-2029
6.4.4 Canada Semi-solid Dosage Market Size, 2018-2029
6.4.5 Mexico Semi-solid Dosage Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Semi-solid Dosage Revenue, 2018-2029
6.5.2 By Country – Europe Semi-solid Dosage Sales, 2018-2029
6.5.3 Germany Semi-solid Dosage Market Size, 2018-2029
6.5.4 France Semi-solid Dosage Market Size, 2018-2029
6.5.5 U.K. Semi-solid Dosage Market Size, 2018-2029
6.5.6 Italy Semi-solid Dosage Market Size, 2018-2029
6.5.7 Russia Semi-solid Dosage Market Size, 2018-2029
6.5.8 Nordic Countries Semi-solid Dosage Market Size, 2018-2029
6.5.9 Benelux Semi-solid Dosage Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Semi-solid Dosage Revenue, 2018-2029
6.6.2 By Region – Asia Semi-solid Dosage Sales, 2018-2029
6.6.3 China Semi-solid Dosage Market Size, 2018-2029
6.6.4 Japan Semi-solid Dosage Market Size, 2018-2029
6.6.5 South Korea Semi-solid Dosage Market Size, 2018-2029
6.6.6 Southeast Asia Semi-solid Dosage Market Size, 2018-2029
6.6.7 India Semi-solid Dosage Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Semi-solid Dosage Revenue, 2018-2029
6.7.2 By Country – South America Semi-solid Dosage Sales, 2018-2029
6.7.3 Brazil Semi-solid Dosage Market Size, 2018-2029
6.7.4 Argentina Semi-solid Dosage Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Semi-solid Dosage Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Semi-solid Dosage Sales, 2018-2029
6.8.3 Turkey Semi-solid Dosage Market Size, 2018-2029
6.8.4 Israel Semi-solid Dosage Market Size, 2018-2029
6.8.5 Saudi Arabia Semi-solid Dosage Market Size, 2018-2029
6.8.6 UAE Semi-solid Dosage Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Semi-solid Dosage Major Product Offerings
7.1.4 Johnson & Johnson Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Merck & Co
7.2.1 Merck & Co Company Summary
7.2.2 Merck & Co Business Overview
7.2.3 Merck & Co Semi-solid Dosage Major Product Offerings
7.2.4 Merck & Co Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.2.5 Merck & Co Key News & Latest Developments
7.3 Bayer AG
7.3.1 Bayer AG Company Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Semi-solid Dosage Major Product Offerings
7.3.4 Bayer AG Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.3.5 Bayer AG Key News & Latest Developments
7.4 Hisamitsu Pharmaceutical
7.4.1 Hisamitsu Pharmaceutical Company Summary
7.4.2 Hisamitsu Pharmaceutical Business Overview
7.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Major Product Offerings
7.4.4 Hisamitsu Pharmaceutical Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.4.5 Hisamitsu Pharmaceutical Key News & Latest Developments
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Company Summary
7.5.2 Glenmark Pharmaceuticals Business Overview
7.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Major Product Offerings
7.5.4 Glenmark Pharmaceuticals Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.5.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.6 Cipla Ltd
7.6.1 Cipla Ltd Company Summary
7.6.2 Cipla Ltd Business Overview
7.6.3 Cipla Ltd Semi-solid Dosage Major Product Offerings
7.6.4 Cipla Ltd Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.6.5 Cipla Ltd Key News & Latest Developments
7.7 Nestle SA
7.7.1 Nestle SA Company Summary
7.7.2 Nestle SA Business Overview
7.7.3 Nestle SA Semi-solid Dosage Major Product Offerings
7.7.4 Nestle SA Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.7.5 Nestle SA Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Semi-solid Dosage Major Product Offerings
7.8.4 Novartis AG Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Company Summary
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Semi-solid Dosage Major Product Offerings
7.9.4 GlaxoSmithKline plc Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline plc Key News & Latest Developments
7.10 Bausch Health Companies
7.10.1 Bausch Health Companies Company Summary
7.10.2 Bausch Health Companies Business Overview
7.10.3 Bausch Health Companies Semi-solid Dosage Major Product Offerings
7.10.4 Bausch Health Companies Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.10.5 Bausch Health Companies Key News & Latest Developments
7.11 Allergan
7.11.1 Allergan Company Summary
7.11.2 Allergan Semi-solid Dosage Business Overview
7.11.3 Allergan Semi-solid Dosage Major Product Offerings
7.11.4 Allergan Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.11.5 Allergan Key News & Latest Developments
7.12 Biofrontera
7.12.1 Biofrontera Company Summary
7.12.2 Biofrontera Semi-solid Dosage Business Overview
7.12.3 Biofrontera Semi-solid Dosage Major Product Offerings
7.12.4 Biofrontera Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.12.5 Biofrontera Key News & Latest Developments
7.13 Crown Laboratories
7.13.1 Crown Laboratories Company Summary
7.13.2 Crown Laboratories Semi-solid Dosage Business Overview
7.13.3 Crown Laboratories Semi-solid Dosage Major Product Offerings
7.13.4 Crown Laboratories Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.13.5 Crown Laboratories Key News & Latest Developments
7.14 Akorn
7.14.1 Akorn Company Summary
7.14.2 Akorn Business Overview
7.14.3 Akorn Semi-solid Dosage Major Product Offerings
7.14.4 Akorn Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.14.5 Akorn Key News & Latest Developments
7.15 Ingenus Pharmaceuticals
7.15.1 Ingenus Pharmaceuticals Company Summary
7.15.2 Ingenus Pharmaceuticals Business Overview
7.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Major Product Offerings
7.15.4 Ingenus Pharmaceuticals Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.15.5 Ingenus Pharmaceuticals Key News & Latest Developments
7.16 Sun Pharmaceuticals
7.16.1 Sun Pharmaceuticals Company Summary
7.16.2 Sun Pharmaceuticals Business Overview
7.16.3 Sun Pharmaceuticals Semi-solid Dosage Major Product Offerings
7.16.4 Sun Pharmaceuticals Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.16.5 Sun Pharmaceuticals Key News & Latest Developments
7.17 Crescita Therapeutics
7.17.1 Crescita Therapeutics Company Summary
7.17.2 Crescita Therapeutics Business Overview
7.17.3 Crescita Therapeutics Semi-solid Dosage Major Product Offerings
7.17.4 Crescita Therapeutics Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.17.5 Crescita Therapeutics Key News & Latest Developments
7.18 Mylan N.V.
7.18.1 Mylan N.V. Company Summary
7.18.2 Mylan N.V. Business Overview
7.18.3 Mylan N.V. Semi-solid Dosage Major Product Offerings
7.18.4 Mylan N.V. Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.18.5 Mylan N.V. Key News & Latest Developments
7.19 Encore Dermatology
7.19.1 Encore Dermatology Company Summary
7.19.2 Encore Dermatology Business Overview
7.19.3 Encore Dermatology Semi-solid Dosage Major Product Offerings
7.19.4 Encore Dermatology Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.19.5 Encore Dermatology Key News & Latest Developments
7.20 LEO Pharma
7.20.1 LEO Pharma Company Summary
7.20.2 LEO Pharma Business Overview
7.20.3 LEO Pharma Semi-solid Dosage Major Product Offerings
7.20.4 LEO Pharma Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.20.5 LEO Pharma Key News & Latest Developments
7.21 Almirall, S.A
7.21.1 Almirall, S.A Company Summary
7.21.2 Almirall, S.A Business Overview
7.21.3 Almirall, S.A Semi-solid Dosage Major Product Offerings
7.21.4 Almirall, S.A Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.21.5 Almirall, S.A Key News & Latest Developments
7.22 Aclaris Therapeutics
7.22.1 Aclaris Therapeutics Company Summary
7.22.2 Aclaris Therapeutics Business Overview
7.22.3 Aclaris Therapeutics Semi-solid Dosage Major Product Offerings
7.22.4 Aclaris Therapeutics Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.22.5 Aclaris Therapeutics Key News & Latest Developments
7.23 Taro Pharmaceutical Industries
7.23.1 Taro Pharmaceutical Industries Company Summary
7.23.2 Taro Pharmaceutical Industries Business Overview
7.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Major Product Offerings
7.23.4 Taro Pharmaceutical Industries Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.23.5 Taro Pharmaceutical Industries Key News & Latest Developments
7.24 Teligent Pharma
7.24.1 Teligent Pharma Company Summary
7.24.2 Teligent Pharma Business Overview
7.24.3 Teligent Pharma Semi-solid Dosage Major Product Offerings
7.24.4 Teligent Pharma Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.24.5 Teligent Pharma Key News & Latest Developments
7.25 Perrigo Pharma
7.25.1 Perrigo Pharma Company Summary
7.25.2 Perrigo Pharma Business Overview
7.25.3 Perrigo Pharma Semi-solid Dosage Major Product Offerings
7.25.4 Perrigo Pharma Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.25.5 Perrigo Pharma Key News & Latest Developments
8 Global Semi-solid Dosage Production Capacity, Analysis
8.1 Global Semi-solid Dosage Production Capacity, 2018-2029
8.2 Semi-solid Dosage Production Capacity of Key Manufacturers in Global Market
8.3 Global Semi-solid Dosage Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Semi-solid Dosage Supply Chain Analysis
10.1 Semi-solid Dosage Industry Value Chain
10.2 Semi-solid Dosage Upstream Market
10.3 Semi-solid Dosage Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Semi-solid Dosage Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Semi-solid Dosage in Global Market
Table 2. Top Semi-solid Dosage Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Semi-solid Dosage Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Semi-solid Dosage Revenue Share by Companies, 2018-2023
Table 5. Global Semi-solid Dosage Sales by Companies, (K Units), 2018-2023
Table 6. Global Semi-solid Dosage Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Semi-solid Dosage Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Semi-solid Dosage Product Type
Table 9. List of Global Tier 1 Semi-solid Dosage Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Semi-solid Dosage Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Semi-solid Dosage Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Semi-solid Dosage Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Semi-solid Dosage Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Semi-solid Dosage Sales (K Units), 2018-2023
Table 15. By Type - Global Semi-solid Dosage Sales (K Units), 2024-2029
Table 16. By Application – Global Semi-solid Dosage Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Semi-solid Dosage Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Semi-solid Dosage Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Semi-solid Dosage Sales (K Units), 2018-2023
Table 20. By Application - Global Semi-solid Dosage Sales (K Units), 2024-2029
Table 21. By Region – Global Semi-solid Dosage Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Semi-solid Dosage Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Semi-solid Dosage Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Semi-solid Dosage Sales (K Units), 2018-2023
Table 25. By Region - Global Semi-solid Dosage Sales (K Units), 2024-2029
Table 26. By Country - North America Semi-solid Dosage Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Semi-solid Dosage Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Semi-solid Dosage Sales, (K Units), 2018-2023
Table 29. By Country - North America Semi-solid Dosage Sales, (K Units), 2024-2029
Table 30. By Country - Europe Semi-solid Dosage Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Semi-solid Dosage Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Semi-solid Dosage Sales, (K Units), 2018-2023
Table 33. By Country - Europe Semi-solid Dosage Sales, (K Units), 2024-2029
Table 34. By Region - Asia Semi-solid Dosage Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Semi-solid Dosage Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Semi-solid Dosage Sales, (K Units), 2018-2023
Table 37. By Region - Asia Semi-solid Dosage Sales, (K Units), 2024-2029
Table 38. By Country - South America Semi-solid Dosage Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Semi-solid Dosage Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Semi-solid Dosage Sales, (K Units), 2018-2023
Table 41. By Country - South America Semi-solid Dosage Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Semi-solid Dosage Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Semi-solid Dosage Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Semi-solid Dosage Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Semi-solid Dosage Sales, (K Units), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Semi-solid Dosage Product Offerings
Table 48. Johnson & Johnson Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Merck & Co Company Summary
Table 51. Merck & Co Semi-solid Dosage Product Offerings
Table 52. Merck & Co Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merck & Co Key News & Latest Developments
Table 54. Bayer AG Company Summary
Table 55. Bayer AG Semi-solid Dosage Product Offerings
Table 56. Bayer AG Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer AG Key News & Latest Developments
Table 58. Hisamitsu Pharmaceutical Company Summary
Table 59. Hisamitsu Pharmaceutical Semi-solid Dosage Product Offerings
Table 60. Hisamitsu Pharmaceutical Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Hisamitsu Pharmaceutical Key News & Latest Developments
Table 62. Glenmark Pharmaceuticals Company Summary
Table 63. Glenmark Pharmaceuticals Semi-solid Dosage Product Offerings
Table 64. Glenmark Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Glenmark Pharmaceuticals Key News & Latest Developments
Table 66. Cipla Ltd Company Summary
Table 67. Cipla Ltd Semi-solid Dosage Product Offerings
Table 68. Cipla Ltd Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Cipla Ltd Key News & Latest Developments
Table 70. Nestle SA Company Summary
Table 71. Nestle SA Semi-solid Dosage Product Offerings
Table 72. Nestle SA Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Nestle SA Key News & Latest Developments
Table 74. Novartis AG Company Summary
Table 75. Novartis AG Semi-solid Dosage Product Offerings
Table 76. Novartis AG Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Novartis AG Key News & Latest Developments
Table 78. GlaxoSmithKline plc Company Summary
Table 79. GlaxoSmithKline plc Semi-solid Dosage Product Offerings
Table 80. GlaxoSmithKline plc Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. GlaxoSmithKline plc Key News & Latest Developments
Table 82. Bausch Health Companies Company Summary
Table 83. Bausch Health Companies Semi-solid Dosage Product Offerings
Table 84. Bausch Health Companies Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Bausch Health Companies Key News & Latest Developments
Table 86. Allergan Company Summary
Table 87. Allergan Semi-solid Dosage Product Offerings
Table 88. Allergan Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Allergan Key News & Latest Developments
Table 90. Biofrontera Company Summary
Table 91. Biofrontera Semi-solid Dosage Product Offerings
Table 92. Biofrontera Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Biofrontera Key News & Latest Developments
Table 94. Crown Laboratories Company Summary
Table 95. Crown Laboratories Semi-solid Dosage Product Offerings
Table 96. Crown Laboratories Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Crown Laboratories Key News & Latest Developments
Table 98. Akorn Company Summary
Table 99. Akorn Semi-solid Dosage Product Offerings
Table 100. Akorn Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Akorn Key News & Latest Developments
Table 102. Ingenus Pharmaceuticals Company Summary
Table 103. Ingenus Pharmaceuticals Semi-solid Dosage Product Offerings
Table 104. Ingenus Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Ingenus Pharmaceuticals Key News & Latest Developments
Table 106. Sun Pharmaceuticals Company Summary
Table 107. Sun Pharmaceuticals Semi-solid Dosage Product Offerings
Table 108. Sun Pharmaceuticals Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Sun Pharmaceuticals Key News & Latest Developments
Table 110. Crescita Therapeutics Company Summary
Table 111. Crescita Therapeutics Semi-solid Dosage Product Offerings
Table 112. Crescita Therapeutics Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Crescita Therapeutics Key News & Latest Developments
Table 114. Mylan N.V. Company Summary
Table 115. Mylan N.V. Semi-solid Dosage Product Offerings
Table 116. Mylan N.V. Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Mylan N.V. Key News & Latest Developments
Table 118. Encore Dermatology Company Summary
Table 119. Encore Dermatology Semi-solid Dosage Product Offerings
Table 120. Encore Dermatology Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Encore Dermatology Key News & Latest Developments
Table 122. LEO Pharma Company Summary
Table 123. LEO Pharma Semi-solid Dosage Product Offerings
Table 124. LEO Pharma Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. LEO Pharma Key News & Latest Developments
Table 126. Almirall, S.A Company Summary
Table 127. Almirall, S.A Semi-solid Dosage Product Offerings
Table 128. Almirall, S.A Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 129. Almirall, S.A Key News & Latest Developments
Table 130. Aclaris Therapeutics Company Summary
Table 131. Aclaris Therapeutics Semi-solid Dosage Product Offerings
Table 132. Aclaris Therapeutics Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 133. Aclaris Therapeutics Key News & Latest Developments
Table 134. Taro Pharmaceutical Industries Company Summary
Table 135. Taro Pharmaceutical Industries Semi-solid Dosage Product Offerings
Table 136. Taro Pharmaceutical Industries Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 137. Taro Pharmaceutical Industries Key News & Latest Developments
Table 138. Teligent Pharma Company Summary
Table 139. Teligent Pharma Semi-solid Dosage Product Offerings
Table 140. Teligent Pharma Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 141. Teligent Pharma Key News & Latest Developments
Table 142. Perrigo Pharma Company Summary
Table 143. Perrigo Pharma Semi-solid Dosage Product Offerings
Table 144. Perrigo Pharma Semi-solid Dosage Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 145. Perrigo Pharma Key News & Latest Developments
Table 146. Semi-solid Dosage Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 147. Global Semi-solid Dosage Capacity Market Share of Key Manufacturers, 2021-2023
Table 148. Global Semi-solid Dosage Production by Region, 2018-2023 (K Units)
Table 149. Global Semi-solid Dosage Production by Region, 2024-2029 (K Units)
Table 150. Semi-solid Dosage Market Opportunities & Trends in Global Market
Table 151. Semi-solid Dosage Market Drivers in Global Market
Table 152. Semi-solid Dosage Market Restraints in Global Market
Table 153. Semi-solid Dosage Raw Materials
Table 154. Semi-solid Dosage Raw Materials Suppliers in Global Market
Table 155. Typical Semi-solid Dosage Downstream
Table 156. Semi-solid Dosage Downstream Clients in Global Market
Table 157. Semi-solid Dosage Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Semi-solid Dosage Segment by Type in 2022
Figure 2. Semi-solid Dosage Segment by Application in 2022
Figure 3. Global Semi-solid Dosage Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Semi-solid Dosage Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Semi-solid Dosage Revenue, 2018-2029 (US$, Mn)
Figure 7. Semi-solid Dosage Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Semi-solid Dosage Revenue in 2022
Figure 9. By Type - Global Semi-solid Dosage Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Semi-solid Dosage Revenue Market Share, 2018-2029
Figure 11. By Type - Global Semi-solid Dosage Sales Market Share, 2018-2029
Figure 12. By Type - Global Semi-solid Dosage Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Semi-solid Dosage Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Semi-solid Dosage Revenue Market Share, 2018-2029
Figure 15. By Application - Global Semi-solid Dosage Sales Market Share, 2018-2029
Figure 16. By Application - Global Semi-solid Dosage Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Semi-solid Dosage Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Semi-solid Dosage Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Semi-solid Dosage Revenue Market Share, 2018-2029
Figure 20. By Region - Global Semi-solid Dosage Sales Market Share, 2018-2029
Figure 21. By Country - North America Semi-solid Dosage Revenue Market Share, 2018-2029
Figure 22. By Country - North America Semi-solid Dosage Sales Market Share, 2018-2029
Figure 23. US Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Semi-solid Dosage Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Semi-solid Dosage Sales Market Share, 2018-2029
Figure 28. Germany Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 29. France Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Semi-solid Dosage Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Semi-solid Dosage Sales Market Share, 2018-2029
Figure 37. China Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 41. India Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Semi-solid Dosage Revenue Market Share, 2018-2029
Figure 43. By Country - South America Semi-solid Dosage Sales Market Share, 2018-2029
Figure 44. Brazil Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Semi-solid Dosage Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Semi-solid Dosage Sales Market Share, 2018-2029
Figure 48. Turkey Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Semi-solid Dosage Revenue, (US$, Mn), 2018-2029
Figure 52. Global Semi-solid Dosage Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Semi-solid Dosage by Region, 2022 VS 2029
Figure 54. Semi-solid Dosage Industry Value Chain
Figure 55. Marketing Channels
